Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Recent Advancement of the Molecular Diagnosis in Pediatric Brain Tumor

  • Bae, Jeong-Mo (Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Won, Jae-Kyung (Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine) ;
  • Park, Sung-Hye (Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine)
  • Received : 2018.03.13
  • Accepted : 2018.04.07
  • Published : 2018.05.01
Download PDF
⟨ Previous Next ⟩

Abstract

Recent discoveries of brain tumor-related genes and fast advances in genomic testing technologies have led to the era of molecular diagnosis of brain tumor. Molecular profiling of brain tumor became the significant step in the diagnosis, the prediction of prognosis and the treatment of brain tumor. Because traditional molecular testing methods have limitations in time and cost for multiple gene tests, next-generation sequencing technologies are rapidly introduced into clinical practice. Targeted sequencing panels using these technologies have been developed for brain tumors. In this article, focused on pediatric brain tumor, key discoveries of brain tumor-related genes are reviewed and cancer panels used in the molecular profiling of brain tumor are discussed.

Keywords

References

  1. Araki A, Chocholous M, Gojo J, Dorfer C, Czech T, Heinzl H, et al. : Chromosome 1q gain and tenascin-C expression are candidate markers to define different risk groups in pediatric posterior fossa ependymoma. Acta Neuropathol Commun 4 : 88, 2016 https://doi.org/10.1186/s40478-016-0349-9
  2. Bai RY, Staedtke V, Rudin CM, Bunz F, Riggins GJ : Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis. Neuro Oncol 17 : 545-554, 2015 https://doi.org/10.1093/neuonc/nou234
  3. Bavle AA, Lin FY, Parsons DW : Applications of genomic sequencing in pediatric CNS tumors. Oncology (Williston Park) 30 : 411-423, 2016
  4. Behling F, Barrantes-Freer A, Skardelly M, Nieser M, Christians A, Stockhammer F, et al. : Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. Diagn Pathol 11 : 55, 2016 https://doi.org/10.1186/s13000-016-0506-2
  5. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, et al. : Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456 : 53-59, 2008 https://doi.org/10.1038/nature07517
  6. Blumenthal DT, Dvir A, Lossos A, Tzuk-Shina T, Lior T, Limon D, et al. : Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients. J Neurooncol 130 : 211-219, 2016 https://doi.org/10.1007/s11060-016-2237-3
  7. Cancer Genome Atlas Research Network : Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 : 1061-1068, 2008 https://doi.org/10.1038/nature07385
  8. Carter JH, McNulty SN, Cimino PJ, Cottrell CE, Heusel JW, Vigh-Conrad KA, et al. : Targeted next-generation sequencing in molecular subtyping of lower-grade diffuse gliomas: application of the World Health Organization's 2016 revised criteria for Central Nervous System Tumors. J Mol Diagn 19 : 328-337, 2017 https://doi.org/10.1016/j.jmoldx.2016.10.010
  9. Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, et al. : Intertumoral heterogeneity within medulloblastoma subgroups. Cancer Cell 31 : 737-754.e6, 2017 https://doi.org/10.1016/j.ccell.2017.05.005
  10. Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, et al. : Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164 : 550-563, 2016 https://doi.org/10.1016/j.cell.2015.12.028
  11. Cho HJ, Myung JK, Kim H, Park CK, Kim SK, Chung CK, et al. : Primary diffuse leptomeningeal glioneuronal tumors. Brain Tumor Pathol 32 : 49-55, 2015 https://doi.org/10.1007/s10014-014-0187-z
  12. Cornejo KM, Cheng L, Church A, Wang M, Jiang Z : Chromosome 12p abnormalities and IMP3 expression in prepubertal pure testicular teratomas. Hum Pathol 49 : 54-60, 2016 https://doi.org/10.1016/j.humpath.2015.10.003
  13. Dal Cin P, Dei Tos AP, Qi H, Giannini C, Furlanetto A, Longatti PL, et al. : Immature teratoma of the pineal gland with isochromosome 12p. Acta Neuropathol 95 : 107-110, 1998
  14. de Bruin TW, Slater RM, Defferrari R, Geurts van Kessel A, Suijkerbuijk RF, Jansen G, et al. : Isochromosome 12p-positive pineal germ cell tumor. Cancer Res 54 : 1542-1544, 1994
  15. Dodgshun AJ, SantaCruz N, Hwang J, Ramkissoon SH, Malkin H, Bergthold G, et al. : Disseminated glioneuronal tumors occurring in childhood: treatment outcomes and BRAF alterations including V600E mutation. J Neurooncol 128 : 293-302, 2016 https://doi.org/10.1007/s11060-016-2109-x
  16. Dougherty MJ, Santi M, Brose MS, Ma C, Resnick AC, Sievert AJ, et al. : Activating mutations in BRAF characterize a spectrum of pediatric lowgrade gliomas. Neuro Oncol 12 : 621-630, 2010 https://doi.org/10.1093/neuonc/noq007
  17. Dubbink HJ, Atmodimedjo PN, Kros JM, French PJ, Sanson M, Idbaih A, et al. : Molecular classification of anaplastic oligodendroglioma using nextgeneration sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro Oncol 18 : 388-400, 2016 https://doi.org/10.1093/neuonc/nov182
  18. Ellison DW, Dalton J, Kocak M, Nicholson SL, Fraga C, Neale G, et al. : Medulloblastoma: clinicopathological correlates of SHH, WNT, and non- SHH/WNT molecular subgroups. Acta Neuropathol 121 : 381-396, 2011 https://doi.org/10.1007/s00401-011-0800-8
  19. Gajjar A, Pfister SM, Taylor MD, Gilbertson RJ : Molecular insights into pediatric brain tumors have the potential to transform therapy. Clin Cancer Res 20 : 5630-5640, 2014 https://doi.org/10.1158/1078-0432.CCR-14-0833
  20. Gardiman MP, Fassan M, Orvieto E, D'Avella D, Denaro L, Calderone M, et al. : Diffuse leptomeningeal glioneuronal tumors: a new entity? Brain Pathol 20 : 361-366, 2010 https://doi.org/10.1111/j.1750-3639.2009.00285.x
  21. Gessi M, Zur Muehlen A, Lauriola L, Gardiman MP, Giangaspero F, Pietsch T : TP53, beta-Catenin and c-myc/N-myc status in embryonal tumours with ependymoblastic rosettes. Neuropathol Appl Neurobiol 37 : 406-413, 2011 https://doi.org/10.1111/j.1365-2990.2010.01151.x
  22. Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, et al. : Subtypes of medulloblastoma have distinct developmental origins. Nature 468 : 1095-1099, 2010 https://doi.org/10.1038/nature09587
  23. Hasselblatt M, Gesk S, Oyen F, Rossi S, Viscardi E, Giangaspero F, et al. : Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol 35 : 933-935, 2011 https://doi.org/10.1097/PAS.0b013e3182196a39
  24. Helfferich J, Nijmeijer R, Brouwer OF, Boon M, Fock A, Hoving EW, et al. : Neurofibromatosis type 1 associated low grade gliomas: a comparison with sporadic low grade gliomas. Crit Rev Oncol Hematol 104 : 30- 41, 2016 https://doi.org/10.1016/j.critrevonc.2016.05.008
  25. Hood L, Rowen L : The Human Genome Project: big science transforms biology and medicine. Genome Med 5 : 79, 2013 https://doi.org/10.1186/gm483
  26. Hoshide R, Jandial R : 2016 World Health Organization classification of central nervous system tumors: an era of molecular biology. World Neurosurg 94 : 561-562, 2016 https://doi.org/10.1016/j.wneu.2016.07.082
  27. Jennings LJ, Arcila ME, Corless C, Kamel-Reid S, Lubin IM, Pfeifer J, et al. : Guidelines for validation of next-generation sequencing-Based oncology panels: a joint consensus recommendation of the Association for Molecular Pathology and College of American Pathologists. J Mol Diagn 19 : 341-365, 2017 https://doi.org/10.1016/j.jmoldx.2017.01.011
  28. Johnson A, Severson E, Gay L, Vergilio JA, Elvin J, Suh J, et al. : Comprehensive genomic profiling of 282 pediatric low- and high-grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures. Oncologist 22 : 1478-1490, 2017 https://doi.org/10.1634/theoncologist.2017-0242
  29. Joyon N, Tauziede-Espariat A, Alentorn A, Giry M, Castel D, Capelle L, et al. : K27M mutation in H3F3A in ganglioglioma grade I with spontaneous malignant transformation extends the histopathological spectrum of the histone H3 oncogenic pathway. Neuropathol Appl Neurobiol 43 : 271-276, 2017 https://doi.org/10.1111/nan.12329
  30. Kallappagoudar S, Yadav RK, Lowe BR, Partridge JF : Histone H3 mutations--a special role for H3.3 in tumorigenesis? Chromosoma 124 : 177-189, 2015 https://doi.org/10.1007/s00412-015-0510-4
  31. Karajannis MA, Legault G, Fisher MJ, Milla SS, Cohen KJ, Wisoff JH, et al. : Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. Neuro Oncol 16 : 1408-1416, 2014 https://doi.org/10.1093/neuonc/nou059
  32. Keedy VL, Temin S, Somerfield MR, Beasley MB, Johnson DH, McShane LM, et al. : American Society of Clinical Oncology provisional clinical opinion : epidermal growth factor receptor (EGFR) Mutation testing for patients with advanced non-small-cell lung cancer considering first-line EGFR tyrosine kinase inhibitor therapy. J Clin Oncol 29 : 2121-2127, 2011 https://doi.org/10.1200/JCO.2010.31.8923
  33. Khuong-Quang DA, Buczkowicz P, Rakopoulos P, Liu XY, Fontebasso AM, Bouffet E, et al. : K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas. Acta Neuropathol 124 : 439-447, 2012 https://doi.org/10.1007/s00401-012-0998-0
  34. Kim J, Park WY, Kim NKD, Jang SJ, Chun SM, Sung CO, et al. : Good laboratory standards for clinical next-generation sequencing cancer panel tests. J Pathol Transl Med 51 : 191-204, 2017 https://doi.org/10.4132/jptm.2017.03.14
  35. Kleinman CL, Gerges N, Papillon-Cavanagh S, Sin-Chan P, Pramatarova A, Quang DA, et al. : Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR. Nat Genet 46 : 39-44, 2014 https://doi.org/10.1038/ng.2849
  36. Kline CN, Joseph NM, Grenert JP, van Ziffle J, Talevich E, Onodera C, et al. : Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro Oncol 19 : 699-709, 2017
  37. Korshunov A, Sturm D, Ryzhova M, Hovestadt V, Gessi M, Jones DT, et al. : Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity. Acta Neuropathol 128 : 279-289, 2014 https://doi.org/10.1007/s00401-013-1228-0
  38. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, et al. : The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131 : 803-820, 2016 https://doi.org/10.1007/s00401-016-1545-1
  39. Masui K, Mischel PS, Reifenberger G : Molecular classification of gliomas. Handb Clin Neurol 134 : 97-120, 2016
  40. Metzker ML : Sequencing technologies - the next generation. Nat Rev Genet 11 : 31-46, 2010 https://doi.org/10.1038/nrg2626
  41. Mostert M, Rosenberg C, Stoop H, Schuyer M, Timmer A, Oosterhuis W, et al. : Comparative genomic and in situ hybridization of germ cell tumors of the infantile testis. Lab Invest 80 : 1055-1064, 2000 https://doi.org/10.1038/labinvest.3780110
  42. Movassaghi M, Shabihkhani M, Hojat SA, Williams RR, Chung LK, Im K, et al. : Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats. Exp Mol Pathol 103 : 87-93, 2017 https://doi.org/10.1016/j.yexmp.2017.06.006
  43. Nambirajan A, Malgulwar PB, Sharma MC, Singh A, Pathak P, Satyarthee GD, et al. : C11orf95-RELA fusion present in a primary intracranial extraaxial ependymoma: report of a case with literature review. Neuropathology 36 : 490-495, 2016 https://doi.org/10.1111/neup.12299
  44. Nikbakht H, Panditharatna E, Mikael LG, Li R, Gayden T, Osmond M, et al. : Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma. Nat Commun 7 : 11185, 2016 https://doi.org/10.1038/ncomms11185
  45. Nikiforova MN, Wald AI, Melan MA, Roy S, Zhong S, Hamilton RL, et al. : Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors. Neuro Oncol 18 : 379-387, 2016 https://doi.org/10.1093/neuonc/nov289
  46. Nobusawa S, Hirato J, Yokoo H : Molecular genetics of ependymomas and pediatric diffuse gliomas : a short review. Brain Tumor Pathol 31 : 229-233, 2014. https://doi.org/10.1007/s10014-014-0200-6
  47. Nobusawa S, Orimo K, Horiguchi K, Ikota H, Yokoo H, Hirato J, et al. : Embryonal tumor with abundant neuropil and true rosettes with only one structure suggestive of an ependymoblastic rosette. Pathol Int 64 : 472-477, 2014 https://doi.org/10.1111/pin.12196
  48. Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, et al. : The whole-genome landscape of medulloblastoma subtypes. Nature 547 : 311-317, 2017 https://doi.org/10.1038/nature22973
  49. Okada Y, Nishikawa R, Matsutani M, Louis DN : Hypomethylated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors. J Neuropathol Exp Neurol 61 : 531-538, 2002 https://doi.org/10.1093/jnen/61.6.531
  50. Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, et al. : Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27 : 728-743, 2015 https://doi.org/10.1016/j.ccell.2015.04.002
  51. Parker M, Mohankumar KM, Punchihewa C, Weinlich R, Dalton JD, Li Y, et al. : C11orf95-RELA fusions drive oncogenic $NF-{\kappa}B$ signalling in ependymoma. Nature 506 : 451-455, 2014 https://doi.org/10.1038/nature13109
  52. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, et al. : An integrated genomic analysis of human glioblastoma multiforme. Science 321 : 1807-1812, 2008 https://doi.org/10.1126/science.1164382
  53. Pietsch T, Haberler C : Update on the integrated histopathological and genetic classification of medulloblastoma - a practical diagnostic guideline. Clin Neuropathol 35 : 344-352, 2016 https://doi.org/10.5414/NP300999
  54. Poulos C, Cheng L, Zhang S, Gersell DJ, Ulbright TM : Analysis of ovarian teratomas for isochromosome 12p: evidence supporting a dual histogenetic pathway for teratomatous elements. Mod Pathol 19 : 766-771, 2006 https://doi.org/10.1038/modpathol.3800596
  55. Qaddoumi I, Orisme W, Wen J, Santiago T, Gupta K, Dalton JD, et al. : Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology. Acta Neuropathol 131 : 833-845, 2016 https://doi.org/10.1007/s00401-016-1539-z
  56. Ramkissoon SH, Bandopadhayay P, Hwang J, Ramkissoon LA, Greenwald NF, Schumacher SE, et al. : Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors. Neuro Oncol 19 : 986-996, 2017
  57. Rickert CH, Simon R, Bergmann M, Dockhorn-Dworniczak B, Paulus W : Comparative genomic hybridization in pineal germ cell tumors. J Neuropathol Exp Neurol 59 : 815-821, 2000 https://doi.org/10.1093/jnen/59.9.815
  58. Roth JJ, Santi M, Pollock AN, Harding BN, Rorke-Adams LB, Tooke LS, et al. : Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade gliomas. Brain Pathol 25 : 182-192, 2015 https://doi.org/10.1111/bpa.12167
  59. Sahm F, Schrimpf D, Jones DT, Meyer J, Kratz A, Reuss D, et al. : Nextgeneration sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets. Acta Neuropathol 131 : 903-910, 2016 https://doi.org/10.1007/s00401-015-1519-8
  60. Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, et al. : Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121 : 397-405, 2011 https://doi.org/10.1007/s00401-011-0802-6
  61. Schneider DT, Schuster AE, Fritsch MK, Calaminus G, Harms D, Gobel U, et al. : Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. Klin Padiatr 213 : 204-211, 2001 https://doi.org/10.1055/s-2001-16852
  62. Schneider DT, Zahn S, Sievers S, Alemazkour K, Reifenberger G, Wiestler OD, et al. : Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization. Mod Pathol 19 : 864-873, 2006 https://doi.org/10.1038/modpathol.3800607
  63. Schulte SL, Waha A, Steiger B, Denkhaus D, Dorner E, Calaminus G, et al. : CNS germinomas are characterized by global demethylation, chromosomal instability and mutational activation of the Kit-, Ras/Raf/Erk- and Akt-pathways. Oncotarget 7 : 55026-55042, 2016
  64. Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, et al. : Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482 : 226-231, 2012 https://doi.org/10.1038/nature10833
  65. Schweizer Y, Meszaros Z, Jones DTW, Koelsche C, Boudalil M, Fiesel P, et al. : Molecular transition of an adult low-grade brain tumor to an atypical teratoid/rhabdoid tumor over a time-course of 14 years. J Neuropathol Exp Neurol 76 : 655-664, 2017 https://doi.org/10.1093/jnen/nlx044
  66. Silver SA, Wiley JM, Perlman EJ : DNA ploidy analysis of pediatric germ cell tumors. Mod Pathol 7 : 951-956, 1994
  67. Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. : Identification of the transforming EML4-ALK fusion gene in non-smallcell lung cancer. Nature 448 : 561-566, 2007 https://doi.org/10.1038/nature05945
  68. Solomon DA, Wood MD, Tihan T, Bollen AW, Gupta N, Phillips JJ, et al. : Diffuse midline gliomas with histone H3-K27M mutation: a series of 47 cases assessing the spectrum of morphologic variation and associated genetic alterations. Brain Pathol 26 : 569-580, 2016 https://doi.org/10.1111/bpa.12336
  69. Spence T, Perotti C, Sin-Chan P, Picard D, Wu W, Singh A, et al. : A novel C19MC amplified cell line links Lin28/let-7 to mTOR signaling in embryonal tumor with multilayered rosettes. Neuro Oncol 16 : 62-71, 2014 https://doi.org/10.1093/neuonc/not162
  70. Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, et al. : New brain tumor entities emerge from molecular classification of CNSPNETs. Cell 164 : 1060-1072, 2016 https://doi.org/10.1016/j.cell.2016.01.015
  71. Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, et al. : Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22 : 425-437, 2012 https://doi.org/10.1016/j.ccr.2012.08.024
  72. Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, et al. : Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123 : 465-472, 2012 https://doi.org/10.1007/s00401-011-0922-z
  73. Tomic TT, Olausson J, Wilzen A, Sabel M, Truve K, Sjogren H, et al. : A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma. PLoS One 12 : e0175638, 2017 https://doi.org/10.1371/journal.pone.0175638
  74. Trabelsi S, Chabchoub I, Ksira I, Karmeni N, Mama N, Kanoun S, et al. : Molecular diagnostic and prognostic subtyping of gliomas in tunisian population. Mol Neurobiol 54 : 2381-2394, 2017 https://doi.org/10.1007/s12035-016-9805-6
  75. Wong SQ, Li J, Tan AY, Vedururu R, Pang JM, Do H, et al. : Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing. BMC Med Genomics 7 : 23, 2014 https://doi.org/10.1186/1755-8794-7-23
  76. Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, et al. : Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44 : 251-253, 2012 https://doi.org/10.1038/ng.1102
  77. Wu J, Armstrong TS, Gilbert MR : Biology and management of ependymomas. Neuro Oncol 18 : 902-913, 2016 https://doi.org/10.1093/neuonc/now016
  78. Yu IT, Griffin CA, Phillips PC, Strauss LC, Perlman EJ : Numerical sex chromosomal abnormalities in pineal teratomas by cytogenetic analysis and fluorescence in situ hybridization. Lab Invest 72 : 419-423, 1995
  79. Zacher A, Kaulich K, Stepanow S, Wolter M, Kohrer K, Felsberg J, et al. : Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel. Brain Pathol 27 : 146-159, 2017 https://doi.org/10.1111/bpa.12367
  80. Zhang C, Berney DM, Hirsch MS, Cheng L, Ulbright TM : Evidence supporting the existence of benign teratomas of the postpubertal testis: a clinical, histopathologic, and molecular genetic analysis of 25 cases. Am J Surg Pathol 37 : 827-835, 2013 https://doi.org/10.1097/PAS.0b013e31827dcc4c
  81. Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, et al. : Wholegenome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45 : 602-612, 2013 https://doi.org/10.1038/ng.2611
  82. Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJ, Martin DC, et al. : Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol 31 : 2927-2935, 2013 https://doi.org/10.1200/JCO.2012.48.5052

Cited by

  1. Preclinical Models of Pediatric Brain Tumors—Forging Ahead vol.5, pp.4, 2018, https://doi.org/10.3390/bioengineering5040081
  2. Glioblastomas in patients with medulloblastomas after combined treatment vol.84, pp.3, 2020, https://doi.org/10.17116/neiro20208403135